AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 786504 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal speaker (audio recording)
Number of subjects: 60
Study 786504 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal speaker (audio recording)
Number of subjects: 60
Study 786504 — intervention group
Group type: COMPARATOR
Intervention: Retouched photograph (eliminating disfigurement)
Number of subjects: 60
Study 31690495 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain omega-3 polyunsaturated fatty acids (n-3 PUFAs)
Number of subjects: 304
Study 31129092 — intervention group
Group type: EXPERIMENTAL
Intervention: Firehawk stent
Number of subjects: 1653
Study 31129092 — intervention group
Group type: COMPARATOR
Intervention: XIENCE stent
Number of subjects: 1653
Study 28399076 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive 10-day health promotion program combining diet and physical activities
Number of subjects: 30
Study 25808741 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 2029
Study 25808741 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2029
Study 23657156 — intervention group
Group type: EXPERIMENTAL
Intervention: High-phytochemical diet rich in cruciferous vegetables, citrus, and soya (F&V)
Number of subjects: 10
Study 23657156 — intervention group
Group type: COMPARATOR
Intervention: Fruit- and vegetable-free (basal) diet
Number of subjects: 10
Study 23657156 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertiles of crucifers, citrus, and soya intake based on 3 d food records
Number of subjects: 10
Study 23657156 — intervention group
Group type: COMPARATOR
Intervention: Tertiles of total fruit and vegetable intake for FFQ
Number of subjects: 10
Study 21367952 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese individuals (BMI ≥30)
Number of subjects: 81
Study 21367952 — intervention group
Group type: COMPARATOR
Intervention: Nonobese individuals (BMI <30)
Number of subjects: 81
Study 21367952 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal-weight individuals (BMI 18-25)
Number of subjects: 81
Study 21367952 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 81
Study 21367952 — intervention group
Group type: COMPARATOR
Intervention: Men
Number of subjects: 81
Study 19125855 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/atorvastatin (5/20 mg) plus therapeutic lifestyle changes (TLC)
Number of subjects: 0
Study 19125855 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus therapeutic lifestyle changes (TLC)
Number of subjects: 0
Study 16959151 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid fluid resuscitation
Number of subjects: 38
Study 16959151 — intervention group
Group type: COMPARATOR
Intervention: General treatment
Number of subjects: 38
Study 14708463 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Colonoscopy (VC)
Number of subjects: 500
Study 14708463 — intervention group
Group type: COMPARATOR
Intervention: Conventional Colonoscopy (CC)
Number of subjects: 500
Study 11198157 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA) with ketorolac
Number of subjects: 0
Study 11198157 — intervention group
Group type: COMPARATOR
Intervention: Standard group with conventional analgesia (ketorolac I.V. 0.5 mg/kg/6 hours)
Number of subjects: 0
Study 9176747 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 100 mg/m2 day 1, etoposide 130 mg/m2 days 1‐3
Number of subjects: 87
Study 9176747 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin 100 mg/m2, vinblastine 6 mg/m2, mitomycin 10 mg/m2 day 1
Number of subjects: 87
Study 9176747 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin-etoposide
Number of subjects: 87
Study 9176747 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin-mitomycin-vinblastine
Number of subjects: 87
Study 1548947 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone only (group I)
Number of subjects: 27
Study 1548947 — intervention group
Group type: COMPARATOR
Intervention: Defined formula diet (Vital HN) only (group II)
Number of subjects: 27
Study 1548947 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of prednisone and Vital HN (group III)
Number of subjects: 27
Study 3697832 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha-methyldopa
Number of subjects: 5
Study 3697832 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 5
Study 31620924 — intervention group
Group type: EXPERIMENTAL
Intervention: VIE intervention (multidisciplinary program including physical activity, nutritional, and psychological interventions)
Number of subjects: 0
Study 31620924 — intervention group
Group type: COMPARATOR
Intervention: Control group (only one evaluation)
Number of subjects: 0
Study 31620924 — intervention group
Group type: EXPERIMENTAL
Intervention: VIE intervention
Number of subjects: 0
Study 31620924 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 30375639 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based ecological intervention (storytelling, discussion, drawing, dramatization)
Number of subjects: 206
Study 30375639 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based ecological intervention
Number of subjects: 206
Study 30375639 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 206
Study 29074964 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in the ENCHANTED trial
Number of subjects: 0
Study 29074964 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in the ENCHANTED trial (specifically in China)
Number of subjects: 0
Study 29074964 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in the ENCHANTED trial (other countries)
Number of subjects: 0
Study 25698099 — intervention group
Group type: EXPERIMENTAL
Intervention: NUTRIC score
Number of subjects: 1199
Study 25698099 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional adequacy
Number of subjects: 1199
Study 24902959 — intervention group
Group type: EXPERIMENTAL
Intervention: Community medicine distributors (CMDs)
Number of subjects: 752
Study 24902959 — intervention group
Group type: COMPARATOR
Intervention: Health facilities
Number of subjects: 752
Study 22991796 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed radiofrequency (PRF) applied for 120 seconds after nerve root block (RB)
Number of subjects: 27
Study 22991796 — intervention group
Group type: COMPARATOR
Intervention: Nerve root block (RB) only
Number of subjects: 27
Study 22991796 — intervention group
Group type: COMPARATOR
Intervention: Comparison between PRF and RB
Number of subjects: 27
Study 19776408 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg per day
Number of subjects: 1176
Study 19776408 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasagiline 2 mg per day
Number of subjects: 1176
Study 17393324 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron (8 mg bid)
Number of subjects: 0
Study 17393324 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 15256191 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 302
Study 15256191 — intervention group
Group type: COMPARATOR
Intervention: Carbamazepine
Number of subjects: 302
Study 15256191 — intervention group
Group type: COMPARATOR
Intervention: Valproate
Number of subjects: 302
Study 11254118 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination drug therapies (including DTIC plus interferon-alpha)
Number of subjects: 3273
Study 11254118 — intervention group
Group type: EXPERIMENTAL
Intervention: DTIC plus interferon-alpha
Number of subjects: 3273
Study 11254118 — intervention group
Group type: EXPERIMENTAL
Intervention: DTIC-containing multi-drug regimens
Number of subjects: 3273
Study 11254118 — intervention group
Group type: COMPARATOR
Intervention: Non-DTIC-containing treatment programmes
Number of subjects: 3273
Study 9883438 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre-free alginate dressing (Comfeel SeaSorb)
Number of subjects: 17
Study 9883438 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (paraffin-impregnated gauze, Jelonet)
Number of subjects: 17
Study 7715293 — intervention group
Group type: EXPERIMENTAL
Intervention: Bengal-3
Number of subjects: 16
Study 7715293 — intervention group
Group type: EXPERIMENTAL
Intervention: MO10
Number of subjects: 16
Study 7715293 — intervention group
Group type: EXPERIMENTAL
Intervention: VRI-16
Number of subjects: 16
Study 7715293 — intervention group
Group type: EXPERIMENTAL
Intervention: Bengal-15
Number of subjects: 16
Study 7715293 — intervention group
Group type: EXPERIMENTAL
Intervention: Bengal-15 (10^8 CFU)
Number of subjects: 16
Study 7715293 — intervention group
Group type: COMPARATOR
Intervention: Buffer recipients
Number of subjects: 16
Study 7715293 — intervention group
Group type: COMPARATOR
Intervention: Challenge with V cholerae O139
Number of subjects: 16
Study 2619027 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release dihydrocodeine
Number of subjects: 40
Study 2619027 — intervention group
Group type: COMPARATOR
Intervention: Escape analgesia
Number of subjects: 40
Study 2619027 — intervention group
Group type: COMPARATOR
Intervention: Antiemetic therapy
Number of subjects: 40
Study 2619027 — intervention group
Group type: COMPARATOR
Intervention: Significant nausea and vomiting
Number of subjects: 40
Study 834966 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum calcitonin levels during acute pancreatitis
Number of subjects: 29
Study 834966 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal Ct-values after 10 days of symptoms
Number of subjects: 29
Study 834966 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum calcium levels
Number of subjects: 29
Study 834966 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitonin release in hyperparathyroidism
Number of subjects: 29
Study 31776447 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher polygenic risk score
Number of subjects: 7319
Study 31776447 — intervention group
Group type: COMPARATOR
Intervention: Germline risk SNPs
Number of subjects: 7319
Study 31220046 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent Pneumococcal Meningitis (RPM) cases
Number of subjects: 24
Study 28759396 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mL syringe for 2-mL dose
Number of subjects: 491
Study 28759396 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-mL syringe for 7.5-mL dose
Number of subjects: 491
Study 28759396 — intervention group
Group type: EXPERIMENTAL
Intervention: Milliliter/teaspoon labels and tools
Number of subjects: 491
Study 28759396 — intervention group
Group type: EXPERIMENTAL
Intervention: Text only instructions
Number of subjects: 491
Study 25657355 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year extension of specialised early intervention
Number of subjects: 0
Study 25657355 — intervention group
Group type: COMPARATOR
Intervention: Step-down care
Number of subjects: 0
Study 23880373 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-back task trials
Number of subjects: 9
Study 23880373 — intervention group
Group type: COMPARATOR
Intervention: 0-back task trials
Number of subjects: 9
Study 23880373 — intervention group
Group type: EXPERIMENTAL
Intervention: Both tasks
Number of subjects: 9
Study 21826680 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided antidromic sensory nerve conduction study (NCS)
Number of subjects: 0
Study 21826680 — intervention group
Group type: COMPARATOR
Intervention: Previous technique (not specified)
Number of subjects: 0
Study 21826680 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 0
Study 19851159 — intervention group
Group type: EXPERIMENTAL
Intervention: USG guided injection (triamcinolone 40 mg)
Number of subjects: 60
Study 19851159 — intervention group
Group type: COMPARATOR
Intervention: LMG guided injection (triamcinolone 40 mg)
Number of subjects: 60
Study 19851159 — intervention group
Group type: EXPERIMENTAL
Intervention: USG guided injection
Number of subjects: 60
Study 19851159 — intervention group
Group type: COMPARATOR
Intervention: LMG guided injection
Number of subjects: 60
Study 16720966 — intervention group
Group type: EXPERIMENTAL
Intervention: Function-centred treatment (FCT) group with Functional Capacity Evaluation (FCE) results available to physicians.
Number of subjects: 0
Study 16720966 — intervention group
Group type: COMPARATOR
Intervention: Pain-centred treatment (PCT) group without FCE results available to physicians.
Number of subjects: 0
Study 14707315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole 0.25‐4.0 mg once daily
Number of subjects: 284
Study 14707315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 284
Study 14707315 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropinirole
Number of subjects: 284
Study 11583826 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE-inhibitors and steroids
Number of subjects: 0
Study 11583826 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly active anti-retroviral therapy
Number of subjects: 0
Study 9207158 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant with standard cauterization
Number of subjects: 149
Study 9207158 — intervention group
Group type: COMPARATOR
Intervention: Cauterization alone (Control)
Number of subjects: 149
Study 8488128 — intervention group
Group type: EXPERIMENTAL
Intervention: Oligoantigenic regimen (including 8 simple foods) for 4 weeks
Number of subjects: 43
Study 8488128 — intervention group
Group type: COMPARATOR
Intervention: No diet nor pharmacological prophylaxis (Control group B)
Number of subjects: 43
Study 6360111 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthokeratology treatment group
Number of subjects: 0
Study 6360111 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 31668907 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricothyroid Visor Maneuver (CVM)
Number of subjects: 88
Study 31668907 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Circumlaryngeal Therapy (MCT)
Number of subjects: 88
Study 31668907 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no treatment)
Number of subjects: 88
Study 30340794 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 week exercise intervention
Number of subjects: 150
Study 30340794 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 30030480 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 88
Study 27082620 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal penile nerve block (DPNB) with 15 mL of 0.33% ropivacaine
Number of subjects: 58
Study 27082620 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tramadol 1.5 mg/kg
Number of subjects: 58
Study 23665883 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexketoprofen trometamol
Number of subjects: 52
Study 23665883 — intervention group
Group type: COMPARATOR
Intervention: Meperidine HCl
Number of subjects: 52
Study 23665883 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study 22221319 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-week dietary intervention containing several anti-inflammatory ingredients
Number of subjects: 36
Study 19712211 — intervention group
Group type: EXPERIMENTAL
Intervention: Search filters for retrieving RCTs from medline
Number of subjects: 161
Study 17237729 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral temperature (NT)
Number of subjects: 2
Study 17237729 — intervention group
Group type: COMPARATOR
Intervention: Comfort temperature (CT)
Number of subjects: 2
Study 16948810 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection before pneumatic dilatation
Number of subjects: 54
Study 16948810 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic dilatation alone
Number of subjects: 54
Study 15205229 — intervention group
Group type: EXPERIMENTAL
Intervention: FC latanoprost/timolol
Number of subjects: 325
Study 15205229 — intervention group
Group type: COMPARATOR
Intervention: UFC brimonidine/timolol
Number of subjects: 325
Study 10816401 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 60
Study 10816401 — intervention group
Group type: COMPARATOR
Intervention: Plain abdominal radiography (AXR)
Number of subjects: 60
Study 8669519 — intervention group
Group type: EXPERIMENTAL
Intervention: Social-behavioral curricula in schools, peer leadership, parental involvement/education, and communitywide task force activities (implemented for 3 school years from 1991 to 1994)
Number of subjects: 0
Study 8669519 — intervention group
Group type: COMPARATOR
Intervention: Reference districts (control group)
Number of subjects: 0
Study 1775253 — intervention group
Group type: EXPERIMENTAL
Intervention: High and low sodium dialysate (HLSD)
Number of subjects: 6
Study 1775253 — intervention group
Group type: COMPARATOR
Intervention: Standard haemodialysis (HD)
Number of subjects: 6
Study 6828829 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound treatment (1 Watt/cm2)
Number of subjects: 7
Study 6828829 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 7
Study 6828829 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound treatment in lidocaine blocked fibromyotic muscle
Number of subjects: 7
Study 6828829 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound treatment in normal lidocaine pretreated muscle
Number of subjects: 7
Study 31964381 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrafractional vaginal dilation using a tampon of a specific diameter during treatment.
Number of subjects: 60
Study 31964381 — intervention group
Group type: COMPARATOR
Intervention: Standard (chemo) radiation with a total dose of 45-50.4 Gy to the pelvic and inguinal nodes with a boost to the anal canal up to 54-60 Gy.
Number of subjects: 60
Study 31964381 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily use of a tampon during treatment.
Number of subjects: 60
Study 31964381 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of a vaginal dilator.
Number of subjects: 60
Study 31964381 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life assessment.
Number of subjects: 60
Study 30862274 — intervention group
Group type: EXPERIMENTAL
Intervention: Seated TSTM
Number of subjects: 60
Study 30862274 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine TSTM
Number of subjects: 60
Study 30862274 — intervention group
Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 60
Study 28930830 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL 0.3% ropivacaine plus 2 mL 1.0 μg/kg dexmedetomidine (group DR)
Number of subjects: 50
Study 28930830 — intervention group
Group type: COMPARATOR
Intervention: 20 mL 0.3% ropivacaine plus 2 mL normal saline (group R)
Number of subjects: 50
Study 28930830 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (group R and group DR)
Number of subjects: 50
Study 25755255 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton beam therapy (PBT)
Number of subjects: 44
Study 25755255 — intervention group
Group type: COMPARATOR
Intervention: X-ray chemoradiotherapy
Number of subjects: 44
Study 24016546 — intervention group
Group type: EXPERIMENTAL
Intervention: SICTRA (saline‐irrigated cooled tip radiofrequency ablation)
Number of subjects: 95
Study 24016546 — intervention group
Group type: COMPARATOR
Intervention: Catheter ablation
Number of subjects: 95
Study 24016546 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated catheter ablation
Number of subjects: 95
Study 21295635 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN) - TWIST system, Semeion
Number of subjects: 2380
Study 18704555 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 20
Study 18704555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 16764215 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (0.7-9 microg/kg)
Number of subjects: 0
Study 16764215 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (17 microg/kg)
Number of subjects: 0
Study 16764215 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (to reverse buprenorphine-induced respiratory depression)
Number of subjects: 0
Study 15233393 — intervention group
Group type: EXPERIMENTAL
Intervention: Rearfoot-forefoot posted orthosis
Number of subjects: 18
Study 15233393 — intervention group
Group type: EXPERIMENTAL
Intervention: High medial longitudinal arch with extrinsic rearfoot post
Number of subjects: 18
Study 15233393 — intervention group
Group type: COMPARATOR
Intervention: No orthosis
Number of subjects: 18
Study 11006919 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g of extra virgin olive oil per day
Number of subjects: 22
Study 11006919 — intervention group
Group type: COMPARATOR
Intervention: 50 g of refined olive oil with no simple phenols
Number of subjects: 22
Study 11006919 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g of extra virgin olive oil (Postprandial trial)
Number of subjects: 22
Study 9351616 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 microg LPS
Number of subjects: 9
Study 9351616 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 microg LPS
Number of subjects: 9
Study 9351616 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 microg LPS
Number of subjects: 9
Study 9351616 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 9
Study 8404558 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 50
Study 8404558 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 50
Study 2938520 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil alone (93 +/- 6 micrograms/kg)
Number of subjects: 27
Study 2938520 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (50 and 100 micrograms/kg) prior to alfentanil
Number of subjects: 27
Study 2938520 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam-alfentanil combination
Number of subjects: 27
Study 31425349 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight-supported overground walking training combined with conventional physiotherapy for 4 weeks
Number of subjects: 37
Study 31425349 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy alone
Number of subjects: 37
Study 28188369 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-stigma at baseline
Number of subjects: 222
Study 28188369 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase of self-stigma from baseline to follow-up
Number of subjects: 222
Study 27020439 — intervention group
Group type: EXPERIMENTAL
Intervention: Uninterrupted use of novel oral anticoagulants (NOACs) (group I, n = 64)
Number of subjects: 192